Related Experiment Video
Updated: Jun 27, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Thrombophilia in children: who to test, how, when, and why?
1Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. raffini@email.chop.edu
Insights
Thrombophilia testing in children is debated. It may benefit adolescents with spontaneous thrombosis or those with a family history, but individualized decisions are crucial for optimal care.
Area of Science:
- Pediatric Hematology
- Thrombosis Research
- Clinical Genetics
Background:
- Pediatric thrombosis and thrombotic risk factors are increasingly recognized.
- The clinical utility of thrombophilia testing in children is under debate.
- Children with thrombosis represent a heterogeneous group requiring tailored approaches.
Purpose of the Study:
- To evaluate the role and utility of thrombophilia testing in pediatric thrombosis.
- To identify pediatric patient subgroups who may benefit most from thrombophilia testing.
- To highlight the need for further research in pediatric thrombosis management.
Main Methods:
- Review of current literature and clinical practices in pediatric thrombosis.
- Analysis of existing data on inherited thrombophilic defects and their association with pediatric venous thromboembolism.
- Discussion of clinical scenarios and decision-making for thrombophilia testing.
Main Results:
- A causative role for inherited prothrombotic defects in many pediatric thrombotic events remains unestablished.
- Adolescents with spontaneous thrombosis and teenage females with a family history are potential candidates for testing.
- Some inherited thrombophilic defects are linked to recurrent venous thromboembolism in children, but management is undetermined.
Conclusions:
- Thrombophilia testing in children should be individualized, particularly for asymptomatic patients with a family history.
- Further prospective longitudinal studies are needed to determine outcomes and optimal management strategies for pediatric thrombosis.
- The unique aspects of childhood thrombosis necessitate specialized research and clinical approaches.
Abstract:
Thrombosis and thrombotic risk factors in children are receiving increased attention, and pediatric hematologists frequently are asked to evaluate children with symptomatic thrombosis, or asymptomatic children who have relatives affected with either thrombosis or thrombophilia. The clinical utility of thrombophilia testing has become increasingly debated, both in adults and children. Children with thrombosis are a heterogeneous group, and it is unlikely that a single approach to testing or treatment is optimal or desirable. A causative role of inherited prothrombotic defects in many pediatric thrombotic events, particularly catheter-related thrombosis, has not been established. Pediatric patients most likely to benefit from thrombophilia testing include adolescents with spontaneous thrombosis and teenage females with a known positive family history who are making choices about contraception. Recent data suggest that some inherited thrombophilic defects are associated with a higher risk of recurrent venous thromboembolism in children, though optimal management of these patients has yet to be determined. The decision to perform thrombophilia testing in asymptomatic patients with a family history should be made on an individual basis after discussion with the family. Given that the field of pediatric thrombosis continues to evolve, and the settings in which many of these events occur are unique to childhood, prospective longitudinal analyses of such patients to determine outcome and response to treatment as well as the impact of known thrombophilic states on these outcomes are clearly needed.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management

